Activation and desensitization of rat A3-adenosine receptors by selective adenosine derivatives and xanthine-7-ribosides

Drug Development Research

Volumn 44, Issue 2-3, 1998, Pages 97-105

  Park, Kyung Sun ^a   Hoffmann, Carsten ^a   Kim, Hea Ok ^a   Padgett, William L ^a   Daly, John W ^a   Brambilla, Roberta ^b   Motta, Cristina ^b   Abbracchio, Maria P ^b   Jacobson, Kenneth A ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Adenosine derivatives; Adenylyl cyclase; Guanine nucleotides; Nucleosides; Xanthines

Indexed keywords

1,3 DIBUTYLXANTHINE 7 RIBOSIDE 5' N METHYLCARBOXAMIDE; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A3 RECEPTOR; ADENOSINE DERIVATIVE; ADENOSINE RECEPTOR STIMULATING AGENT; ADENYLATE CYCLASE; PLAVIS; RECEPTOR SUBTYPE; TAZAROTENE; TROGLITAZONE; UNCLASSIFIED DRUG; XANTHINE 7 RIBOSIDE; XANTHINE DERIVATIVE;

ARTICLE; CHO CELL; ENZYME INHIBITION; NONHUMAN; RAT; RECEPTOR BINDING; RECEPTOR BLOCKING;

EID: 0031660803     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199806/07)44:2/3<97::AID-DDR7>3.0.CO;2-5     Document Type: Article

References (33)

1. 3 receptors in rat brain. Mol Pharmacol 48:1038-1045.
2. Ali H, Cunha-Melo JR, Saul WF, Beavan MF (1990): Activation of phospholipase C via adenosine receptors provides synergistic signals for secretion in antigen stimulated RBL-2H3 cells. J Biol Chem 265:745-753.
3. Bradford MM (1976): A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem 72:248-254.
4. 50) of an enzyme reaction. Biochem Pharmacol 22:3099-3108.
5. 3 receptor-mediated hypotensive responses in the rat. Eur J Pharmacol 252:R5-R6.
6. 3-selective adenosine agonists. J Med Chem 37:636-646.
7. IJzerman AP, van der Wenden EM, von Frijtag Drabbe Kanzel JK, Mathot RA, Danhof M, Borea PA, Varani K (1994): Partial agonism of theophylline-7-riboside on adenosine receptors, Naunyn Schmiedebergs Arch Pharmacol 350:638-645.
8. 3 adenosine receptors: Novel ligands and paradoxical effects. Trends Pharmacol Sci 19:184-191.
9. Jacobson KA, van Galen PJM, Williams M (1992): Perspective. Adenosine receptors: Pharmacology, structure-activity relationships and therapeutic potential. J Med Chem 35:407-422.
10. 3-adenosine receptors: Mediation of behavioral depressant effects. FEBS Lett 336:57-60.
11. 3 adenosine receptors. J Med Chem 38:1720-1735.
12. 3 adenosine receptor-selective antagonists. Neuropharmacology 36:1157-1165.
13. 3-adenosine receptors. Drug Dev Res 33:51-59.
14. 3 adenosine receptor antagonists. J Med Chem 40:2596-2608.
15. 3-adenosine receptors, J Med Chem 37:3373-3382.
16. 3-adenosine receptors: Structure-activity relationships of 1,3-dialkylxanthine-7-riboside derivatives, J Med Chem 37:4020-4030.
17. 3 receptor subtype. J Med Chem 39:4142-4148.
18. 3 receptor: Sustained cardioprotection. Proc Natl Acad Sci USA 95:6995-6999.
19. 1 receptors. J Med Chem 31:745-751.
20. 3 adenosine receptor with widespread tissue distribution. Mol Pharmacol 44:524-532.
21. 3 receptor can mediate preconditioning's protection in isolated rabbit hearts. Cardiovasc Res 28:1057-1061.
22. 1 adenosine receptor with receptor/G protein complexes in rat-brain membranes. Mol Pharmacol 49:915-926.
23. Meyerhof W, Müller-Brechlin R, Richter D (1991): Molecular cloning of a novel putative G-protein coupled receptor expressed during rat spermiogenesis. FEBS Lett 284:155-160.
24. Olah ME, Stiles GL (1995): Adenosine receptor subtypes - Characterization and therapeutic regulation. Annu Rev Pharmacol Toxicol 35:581-606.
25. 3 adenosine receptor. Mol Pharmacol 45:978-982.
26. 3AR is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem 268:16887-16890.
27. 3 adenosine receptor. Proc Natl Acad Sci 90:10365-10369.
28. 3-adenosine receptor. Drug Dev Res 39:36-46.
29. 3 receptors. J Clin Invest 98:1773-1779.
30. Ukena D, Daly JW, Kirk KL, Jacobson KA (1986): Functionalized congeners of 1,3-dipropyl-8-phenylxanthine: Potent antagonists for adenosine receptors that modulate membrane adenylate cyclase in pheochromocytoma cells, platelets and fat cells. Life Sci 38:797-807.
31. 3 receptor stimulation and cerebral ischemia. Eur J Pharmacol 263:59-67.
32. 3 receptor expression and function in eosinophils. Am J Respir Cell Mol Biol 16:531-737.
33. 3 adenosine receptor. Proc Natl Acad Sci USA 89:7432-7436.